PSD3 | Pleckstrin and Sec7 domain containing 3 | | | | | | Tissue enhanced |
SH2D4A | SH2 domain containing 4A | | | | | | Mixed |
CSGALNACT1 | Chondroitin sulfate N-acetylgalactosaminyltransferase 1 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
INTS10 | Integrator complex subunit 10 | | | | | | Expressed in all |
LPL | Lipoprotein lipase | Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SLC18A1 | Solute carrier family 18 (vesicular monoamine transporter), member 1 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ATP6V1B2 | ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2 | FDA approved drug targets Transporters
| | | | | Expressed in all |
LZTS1 | Leucine zipper, putative tumor suppressor 1 | Disease related genes Plasma proteins
| | | | | Mixed |
GFRA2 | GDNF family receptor alpha 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
DOK2 | Docking protein 2, 56kDa | | | | | | Mixed |
XPO7 | Exportin 7 | Predicted membrane proteins
| | | | | Expressed in all |
NPM2 | Nucleophosmin/nucleoplasmin 2 | | | | | | Mixed |
FGF17 | Fibroblast growth factor 17 | Cancer-related genes Disease related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
DMTN | Dematin actin binding protein | Plasma proteins
| | | | | Expressed in all |
FAM160B2 | Family with sequence similarity 160, member B2 | | | | | | Expressed in all |
NUDT18 | Nudix (nucleoside diphosphate linked moiety X)-type motif 18 | Enzymes Predicted secreted proteins
| | | | | Mixed |
HR | Hair growth associated | Disease related genes
| | | | | Tissue enriched |
REEP4 | Receptor accessory protein 4 | Predicted membrane proteins
| | | | | Expressed in all |
LGI3 | Leucine-rich repeat LGI family, member 3 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SFTPC | Surfactant protein C | Disease related genes
| | | | | Tissue enriched |
BMP1 | Bone morphogenetic protein 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
PHYHIP | Phytanoyl-CoA 2-hydroxylase interacting protein | | | | | | Tissue enhanced |
POLR3D | Polymerase (RNA) III (DNA directed) polypeptide D, 44kDa | RNA polymerase related proteins
| | | | | Expressed in all |
PIWIL2 | Piwi-like RNA-mediated gene silencing 2 | | | | | | Tissue enhanced |
SLC39A14 | Solute carrier family 39 (zinc transporter), member 14 | Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
PPP3CC | Protein phosphatase 3, catalytic subunit, gamma isozyme | Enzymes Plasma proteins
| | | | | Expressed in all |
SORBS3 | Sorbin and SH3 domain containing 3 | Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
PDLIM2 | PDZ and LIM domain 2 (mystique) | | | | | | Expressed in all |
AC037459.4 | Uncharacterized protein | | | | | | Tissue enhanced |
C8orf58 | Chromosome 8 open reading frame 58 | | | | | | Expressed in all |
CCAR2 | Cell cycle and apoptosis regulator 2 | | | | | | Expressed in all |
BIN3 | Bridging integrator 3 | Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
EGR3 | Early growth response 3 | Transcription factors
| | | | | Mixed |
PEBP4 | Phosphatidylethanolamine-binding protein 4 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
RHOBTB2 | Rho-related BTB domain containing 2 | | | | | | Mixed |
TNFRSF10B | Tumor necrosis factor receptor superfamily, member 10b | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
TNFRSF10C | Tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain | Cancer-related genes CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
TNFRSF10D | Tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Mixed |
TNFRSF10A | Tumor necrosis factor receptor superfamily, member 10a | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Mixed |
CHMP7 | Charged multivesicular body protein 7 | | | | | | Expressed in all |
R3HCC1 | R3H domain and coiled-coil containing 1 | | | | | | Expressed in all |
LOXL2 | Lysyl oxidase-like 2 | Enzymes Predicted secreted proteins
| | | | | Mixed |
ENTPD4 | Ectonucleoside triphosphate diphosphohydrolase 4 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
SLC25A37 | Solute carrier family 25 (mitochondrial iron transporter), member 37 | Mitochondrial proteins Transporters
| | | | | Expressed in all |
AC051642.1 | | | | | | | Not detected |
FP15737 | | | | | | | Mixed |
NKX3-1 | NK3 homeobox 1 | Cancer-related genes Transcription factors
| | | | | Tissue enriched |
NKX2-6 | NK2 homeobox 6 | Disease related genes Transcription factors
| | | | | Not detected |
STC1 | Stanniocalcin 1 | Predicted secreted proteins
| | | | | Mixed |
ADAM28 | ADAM metallopeptidase domain 28 | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |